Cargando…
Serum Atrial Natriuretic Peptide, NPPA Promoter Methylation, and Cardiovascular Disease: A 10-year Follow-Up Study in Chinese Adults
BACKGROUND: Atrial natriuretic peptide (ANP) has been associated with cardiovascular disease (CVD) and related risk factors, but the clinical application is limited and the underlying mechanisms are not very clear. Here, we aimed to examine whether proANP and its coding gene methylation were associa...
Autores principales: | Chen, Linan, Li, Jing, Zhang, Min, Zhang, Qiu, Wu, Lei, Lu, Ying, He, Yan, Jiang, Jun, Zhang, Xiaolong, Hu, Jianwei, Ding, Yi, Zhang, Mingzhi, Peng, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ubiquity Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992767/ https://www.ncbi.nlm.nih.gov/pubmed/35586748 http://dx.doi.org/10.5334/gh.1116 |
Ejemplares similares
-
Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression
por: Annilo, Tarmo, et al.
Publicado: (2009) -
Association of Common Variants in NPPA and NPPB with Circulating Natriuretic Peptides and Blood Pressure
por: Newton-Cheh, Christopher, et al.
Publicado: (2009) -
Association between NPPA promoter methylation and hypertension: results from Gusu cohort and replication in an independent sample
por: Li, Jing, et al.
Publicado: (2020) -
Case report: Mutation in NPPA gene as a cause of fibrotic atrial myopathy
por: Silva Cunha, Pedro, et al.
Publicado: (2023) -
Loss of GLTSCR1 causes congenital heart defects by regulating NPPA transcription
por: Han, Fengyan, et al.
Publicado: (2023)